Search results

Order by most recent / most popular / relevance

Results: 1-10 of 4,073

Putative class alleges pharma statements about new drug violated securities laws

Shook Hardy & Bacon LLP
-
USA
-
May 16 2013

Aveo Pharmaceuticals, Inc. and several of its executives have been targeted in a securities class action filed in a federal court in Massachusetts

Jury buys plaintiff’s argument that drug manufacturer should have distributed dear doctor letter sooner, without prior FDA approval

Morrison & Foerster LLP
-
USA
-
May 15 2013

Dear Doctor letters were front and center in the just-tried case of Tietz v. Abbott Laboratories, Inc., et al., No. 12-L-002715. On Thursday, May 9

PhRMA pushes for permissive off-label promotion regime

McGuireWoods LLP
-
USA
-
May 15 2013

In light of the decision of 2nd U.S. Circuit Court of Appeals in U.S. v. Caronia, the Pharmaceutical Research and Manufacturers of America (PhRMA) is

EEOC settles first case alleging genetic information bias

Littler Mendelson
-
USA
-
May 15 2013

Last week the Equal Employment Opportunity Commission (EEOC) settled its first lawsuit involving a discrimination claim based on an applicant's

$39 million jury verdict in False Claims Act suit against Tuomey Healthcare

Haynes and Boone LLP
-
USA
-
May 15 2013

Last week, a federal jury in South Carolina found that Tuomey Healthcare System, Inc. violated the Stark Law and the False Claims Act by submitting

Hepatitis B-infected health care professionals gain stronger protection under recent DOJ settlement

Nossaman LLP
-
USA
-
May 15 2013

In March 2013, the U.S. Department of Justice ("DOJ") settled the first lawsuit of its kind with a New Jersey medical school over claims that it

Delaware court: settlement for statutory damages, calculated without reference to actual damages incurred, is for penalty, not covered loss

Wiley Rein LLP
-
USA
-
May 14 2013

A Delaware trial court has held that a settlement for statutory damages paid by a health care organization represents uncovered penalties rather than

Standing and certification: Kennedy v. United Am. Ins. Co

McGuireWoods LLP
-
USA
-
May 14 2013

Brenda Kennedy was hospitalized in 2009 for four days. She had an insurance policy from United American that paid benefits for each day that she

US Airways v. McCutchen: when silence is not golden

Jones Day
-
USA
-
May 14 2013

Sponsors and administrators of self-insured health and welfare plans, as well as insurance companies that offer insured health and welfare products

Generic manufacturer Ranbaxy settles civil and criminal claims based on cGMP violations: a new era of cGMP enforcement actions?

Alston & Bird LLP
-
USA
-
May 14 2013

Yesterday, the Department of Justice (DOJ) announced that it had entered into a $500 million civil and criminal settlement with Ranbaxy USA, Inc

next >

Search results

Putative class alleges pharma statements about new drug violated securities laws

Jury buys plaintiff’s argument that drug manufacturer should have distributed dear doctor letter sooner, without prior FDA approval

PhRMA pushes for permissive off-label promotion regime

EEOC settles first case alleging genetic information bias

$39 million jury verdict in False Claims Act suit against Tuomey Healthcare

Hepatitis B-infected health care professionals gain stronger protection under recent DOJ settlement

Delaware court: settlement for statutory damages, calculated without reference to actual damages incurred, is for penalty, not covered loss

Standing and certification: Kennedy v. United Am. Ins. Co

US Airways v. McCutchen: when silence is not golden

Generic manufacturer Ranbaxy settles civil and criminal claims based on cGMP violations: a new era of cGMP enforcement actions?

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea